Cinacalcet is a drug that lowers levels of parathyroid hormone, a factor that is increased in almost all people with kidney failure and has been linked to an increased risk of fracture, cardiovascular events and death. It has been hoped that by reducing parathyroid hormone with cinacalcet, the risk of these clinical events will also […]
Read More
In order to meet the growing needs of our customers, George Clinical has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second George Clinical office in India in Bengaluru to complement our head office in Hyderabad. With many of our large outcomes studies recruiting patients in India there is […]
Read More
Emeritus Professor Norbert Berend, internationally recognised for his work on chronic obstructive pulmonary disease, has been appointed Head of Respiratory Research at George Clinical. Part of The George Institute for Global Health, George Clinical undertakes large-scale, high-impact clinical trials to provide evidence that influences health policy worldwide. Dr Marisa Petersen, Chief Executive Officer of George […]
Read More
Professor Christine Jenkins has been appointed Professorial Fellow and Head of Respiratory Trials at George Clinical.
Read More
